You are here: Industry Insights > AbbVie

News List

AbbVie's Orilissa scores double uterine fibroids win fiercepharma
December 05, 2018
AbbVie’s Orilissa (elagolix) snagged its first FDA approval over the summer, and now it’s looking to make it two.
AbbVie inks Humira patent deal No. 7, delaying Pfizer's U.S. biosim launch until late 2023 fiercepharma
December 05, 2018
AbbVie is on a hot streak striking patent deals to protect its top drug, Humira. Even as Boehringer Ingelheim has opted to fight the company’s patent claims in court
ASH: Johnson & Johnson, AbbVie's Imbruvica steals the CLL spotlight with phase 3 study wins fiercepharma
December 05, 2018
Johnson & Johnson and AbbVie’s Imbruvica already competes in previously untreated chronic lymphocytic leukemia (CLL). But with a new lineup of head-to-head data, the partners are looking to own it.
AbbVie, Pfizer reach licencing agreement for biosimilar Humira pharmaphorum
December 04, 2018
AbbVie has granted a non-exclusive patent license allowing Pfizer to sell its Humira (adalimumab) biosimilar in many countries around the world.....
Pfizer secures Humira licence agreements with AbbVie pharmaceutical-technology
December 04, 2018
Pfizer has resolved licensing issues regarding its adalimumab biosimilar that was deemed too close to AbbVie’s Humira (adalimumab).....
AbbVie Announces Humira Global Patent License with Pfizer americanpharmaceuticalreview
December 03, 2018
AbbVie announced patent license agreements with Pfizer over its proposed biosimilar adalimumab product. Under the terms of the agreements.....
AbbVie, Roche take Venclexta into AML arena fiercepharma
November 27, 2018
AbbVie and Roche’s Venclexta is leaving familiar territory with its latest approval, and it won’t be an easy land grab. To establish itself on its new turf, the blood cancer drug will have to duke it out with some Big Pharma rivals.
Tolero Pharmaceuticals Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial pharmafocusasia
November 27, 2018
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases...
AbbVie sues NHS over hep C drug procurement scheme pharmaphorum
November 22, 2018
American pharma firm AbbVie is taking NHS England to court over a procurement process aimed to help England become the first country in the world to eradicate the hepatitis C virus (HCV).
Mission Therapeutics team up with AbbVie against Alzheimer's, Parkinson’s biospectrumasia
November 20, 2018
Mission Therapeutics inks a collaboration agreement with AbbVie aimed at developing deubiquitylating enzymes (DUBs) for the potential treatment of Alzheimer's disease and Parkinson's disease.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page